Lithium attenuates dopamine depleting effects of reserpine and tetrabenazine but not that of alpha methyl-p-tyrosine.

Author: FahnS, HassanM N, JacksonV R, RechesA

Paper Details 
Original Abstract of the Article :
Concurrent administration of lithium (Li) significantly attenuates the dopamine (DA) depleting effects of reserpine and tetrabenazine, but does not change alpha-methyl-p-tyrosine (AMPT) induced DA depletion in rat brain. This effect of Li is probably mediated, in part, by inhibiting the magnesium-de...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/0024-3205(83)90408-3

データ提供:米国国立医学図書館(NLM)

Lithium: A Potential Modifier of Dopamine Depletion

Dopamine, a neurotransmitter responsible for regulating mood, movement, and reward, can be affected by certain medications. This research investigates the potential interaction between lithium, a medication used to treat bipolar disorder, and other drugs that influence dopamine levels.

Lithium's Impact on Dopamine Depletion

The study found that lithium significantly attenuated the dopamine-depleting effects of reserpine and tetrabenazine, two drugs known to reduce dopamine levels. This finding suggests that lithium may have a protective effect on dopamine levels, potentially mitigating the side effects of these medications.

Navigating Drug Interactions

This research highlights the importance of considering potential drug interactions when prescribing medications that affect dopamine levels. By understanding the complex interplay between these drugs, healthcare providers can make informed decisions to optimize treatment outcomes and minimize potential side effects.

Dr.Camel's Conclusion

This research explores the intricate interplay between lithium and other drugs that influence dopamine levels. The study's findings suggest that lithium may have a protective effect on dopamine, offering valuable insights for optimizing treatment strategies and minimizing potential drug interactions.

Date :
  1. Date Completed 1983-08-17
  2. Date Revised 2019-07-01
Further Info :

Pubmed ID

6865653

DOI: Digital Object Identifier

10.1016/0024-3205(83)90408-3

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.